Sloan A. Lewis

Sloan A. Lewis

Auto-generated profile, based on publicly available information

Sloan A. Lewis

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, California, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2025 in JCI Insight
Verified
Journal Article
Open access
JDJennifer A. Dantzer
Jennifer A. Dantzer
SLSloan A. Lewis
Sloan A. Lewis
KPKevin J. Psoter
Kevin J. Psoter
ASAaron Sutherland
Aaron Sutherland
AFApril Frazier
April Frazier
RWRobert A. Wood
Robert A. Wood
BACKGROUND: Cow’s milk (CM) allergy is the most common food allergy in young children. Treatment with oral immunotherapy (OIT) has shown efficacy, but high rates of adverse reactions. The aim of this study was to determine whether baked milk OIT (BMOIT) could reduce adverse reactions while still inducing desensitization, and to identify immunological correlates of successful BMOIT. METHODS: This phase II, randomized trial evaluated the safety and efficacy of BMOIT in milk-allergic children 3–18 years old. After the initial placebo-controlled first year of treatment, placebo-treated participants crossed over to active BMOIT. Double-blind, placebo-controlled oral food challenges (OFCs) were conducted with BM after year 1 and to both BM and unheated milk (UM) after year 2. IgG and IgE antibodies were measured along with CM-specific (CM + ) CD4 + memory T cell populations, profiled using flow cytometry and scRNA-Seq. RESULTS: Twenty-one of 30 (70%) reached the primary endpoint of tolerating 4044 mg of BM protein at month 24, and 11 of 30 tolerated 2000 mg or more of UM protein. Dosing symptoms were common, but more than 98% were mild, with no severe reactions. Immunological changes associated with desensitization included increased CM IgG4, CM + FOXP3 + cells, and Tregs and corresponding decreases in CM IgE, CM + Th2A cells, and CD154 + cells. T cell and antibody measurements were combined to build a model that predicted UM OFC outcomes. CONCLUSION: BMOIT was well tolerated and induced desensitization to BM and UM. This desensitization corresponded to redistribution within antigen-specific antibody and T cell compartments that provided insight into the mechanistic changes that occur with OIT treatment. TRIAL REGISTRATION: ClinicalTrials.gov NCT03462030. FUNDING: Myra Reinhardt Family Foundation (grant number 128388), NIH/NIAID (U19AI135731, T32AI125179, S10OD025052):

17 April 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
KKKendall Kearns
Kendall Kearns
SLSloan A. Lewis
Sloan A. Lewis
YDYu Esther Dawen
Yu Esther Dawen
AAAdam Abawi
Adam Abawi
EWEric Wang
Eric Wang
RARicardo da Silva Antunes
Ricardo da Silva Antunes
The role of gamma-delta T (γδ T) cells in immune responses to common allergens is poorly understood. Here, we utilized single-cell (sc) transcriptomic analysis of allergen-reactive γδ T cells in humans to characterize the transcriptional landscapes and TCR repertoires in response to cockroach (CR) and mouse (MO) allergens. Using a potentially novel activation-induced marker (AIM) assay that allows detection of γδ T cells combined with scRNA sequencing and TCR repertoire analysis, we identified both shared and allergen-specific γδ T cell activation patterns and gene expression profiles. While CR extract activated both Vδ1 and Vδ2 subsets, MO extract primarily stimulated Vδ2 cells. Our analysis revealed allergen-specific clusters with distinct functional signatures, including enhanced inflammatory responses and cytotoxic effector functions in MO-specific γδ T cells and natural killer cell–mediated immunity and IFN-γ signaling in CR-specific populations. Comparison of allergic and nonallergic individuals highlighted differences in gene expression and TCR repertoires, including a higher IFNG expression in the CR-allergic compared with nonallergic cohorts, suggesting that phenotypic and functional differences are associated with γδ T allergen responses. This study provides insights into the cellular and molecular heterogeneity and functionality of allergen-reactive γδ T cells, offering a foundation for understanding their role in allergic diseases and potential therapeutic interventions.